Overview

Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacodynamics of single doses of AZD3199 in asthmatic patients.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
AZD-3199
Formoterol Fumarate